O-GlcNAcylation in cancer development and immunotherapy

XF He, X Hu, GJ Wen, Z Wang, WJ Lin - Cancer Letters, 2023 - Elsevier
O-linked β-DN-acetylglucosamine (O-GlcNAc), as a posttranslational modification (PTM), is
a reversible reaction that attaches β-N-GlcNAc to Ser/Thr residues on specific proteins by O …

Tumor-associated glycans and immune surveillance

B Monzavi-Karbassi, A Pashov, T Kieber-Emmons - Vaccines, 2013 - mdpi.com
Changes in cell surface glycosylation are a hallmark of the transition from normal to inflamed
and neoplastic tissue. Tumor-associated carbohydrate antigens (TACAs) challenge our …

[HTML][HTML] Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

LF Hutchins, I Makhoul, PD Emanuel, A Pennisi… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Tumor-associated carbohydrate antigens (TACAs) support cell survival that could be
interrupted by anti-TACA antibodies. Among TACAs that mediate cell survival signals are the …

Analysis of the Human Cancer Glycome Identifies a Novel Group of Tumor-Associated N-Acetylglucosamine Glycan Antigens

T Satomaa, A Heiskanen, I Leonardsson, J Angstrom… - Cancer research, 2009 - AACR
The cell surface is covered by a dense layer of protein-and lipid-linked glycans. Although it
has been known that distinct glycan structures are associated with cancer, the whole …

Carbohydrate moieties as vaccine candidates

AH Lucas, MA Apicella, CE Taylor - Clinical infectious diseases, 2005 - academic.oup.com
Carbohydrate epitopes or glycotopes are structurally diverse, occur in a variety of chemical
contexts, and are present on the surfaces of cells in the body and on the surfaces of …

[HTML][HTML] P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses

I Makhoul, SM Ibrahim, M Abu-Rmaileh… - Oncotarget, 2021 - ncbi.nlm.nih.gov
Breast cancer patients diagnosed with HR+/HER2–tumors face a persistent risk of distant
recurrence long after completion of their treatment. Strategies to induce anti-tumor immune …

Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice

A Wondimu, T Zhang, T Kieber-Emmons… - Cancer Immunology …, 2008 - Springer
Introduction Because of its restricted distribution in normal tissues and its high expression on
tumors of neuroectodermal origin, GD2 ganglioside is an excellent target for active specific …

Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma

TT Liu, Y Wu, T Niu - Oncotarget, 2017 - pmc.ncbi.nlm.nih.gov
Dickkopf-1 (DKK1) is an ideal target for the immunotherapy of multiple myeloma. Heat Shock
protein70 (HSP70) is a class of important molecular chaperone to promote antigen …

Design of peptide-based vaccines for cancer

GA Pietersz, DS Pouniotis… - Frontiers in Medicinal …, 2010 - benthamdirect.com
The immune system responds efficiently to bacteria, viruses and other agents however, the
immune response to cancers is not as effective. In most cases other than specific genetic …

[HTML][HTML] O-GlcNAcylation and immune cell signaling: A review of known and a preview of unknown

P Ramakrishnan - Journal of Biological Chemistry, 2024 - Elsevier
The dynamic and reversible modification of nuclear and cytoplasmic proteins by O-
GlcNAcylation significantly impacts the function and dysfunction of the immune system. O …